The Bank of New York Mellon Corporation
Holds and administers securities and cash in custody for institutional investors and asset managers.
Maintain BNY Mellon at Hold with a two-trigger pre-staged architecture: trim 25-40% of the existing position into any $149-152 relief rally to capture partial gains ahead of the binary earnings catalyst, and add 25% only on a confirmed daily close above $147.45 (10 EMA) with volume ≥ 6M shares and RSI > 40. Hard stop is set at $137.00 on confirmed daily close—the 200 SMA structural support level that must hold for the constructive thesis to remain intact.
28 wins · 10 losses · 6 pushes in 44 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account0.0%
Report archive
Subscribe to read
Subscribe to read
last 30 of 49 reports28 wins · 10 losses · 6 pushes in 44 scored verdicts-0.22% avg move
$10,000 → $10,000
-1.3%
$10,000 → $9,873
too few trades to judge — no round trips yetin the market 0 of 6 sessionsmax drawdown 0.0%simulated 2 Oct – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Maintain BNY Mellon at Hold with a two-trigger pre-staged architecture: trim 25-40% of the existing position into any $149-152 relief rally to capture partial gains ahead of the binary earnings catalyst, and add 25% only on a confirmed daily close above $147.45 (10 EMA) with volume ≥ 6M shares and RSI > 40. Hard stop is set at $137.00 on confirmed daily close—the 200 SMA structural support level that must hold for the constructive thesis to remain intact.
Trim BNY Mellon to 60% of benchmark weight (30-40% reduction) in the $140-$143 zone ahead of Q3 earnings, with stop on remaining position at $136.24 (200 SMA) on confirmed daily close with volume >7M shares. Re-entry requires 10 EMA reclaim at $147.45 with MACD histogram positive cross; mandatory pre-earnings position reduction 5 days before Q3 print. Avoid naked shorting given RSI 25.95 oversold conditions.
Maintain BNY Mellon at Hold with a two-binary-trigger overlay designed to finally produce measurable alpha instead of NaN. Trim to 50% of current weight if price closes below $136.24 (200 SMA) on volume ≥ 8M shares; add 25% to current weight if price closes above $147.45 (10 EMA) on volume ≥ 6M shares with RSI > 40. The 10 EMA reclaim is only 2.6% away versus 5.2% downside to the 200 SMA, making near-term risk-reward slightly negative and justifying Hold over Overweight or Underweight.
Trim BNY to 40-50% of current weight with a $138 stop (2 ATR buffer below 200 SMA), mandating pre-earnings reduction to ≤25-30% of original position ahead of the Q3 2026 print; re-entry only post-earnings via 200 SMA test-and-hold at $136 with bullish reversal or 10 EMA reclaim at $148.28 on above-average volume with positive MACD histogram. This Underweight rating captures the directional trim while avoiding the half-measure failure of prior Hold recommendations and the overreach of a full Sell given BNY's structural floor at the 200 SMA.
Maintain BNY Mellon at Hold with mandated active overlay sized to fully neutralize the documented Hold-bleed base rate, differentiating this Hold from four prior Holds that bled alpha or produced NaN outcomes. Execute via 25-30% trim to neutral if currently overweight, or layer 3-month protective puts at $138-140 strike with full notional if at core weight; hard stop at $134.50 on weekly close basis with pre-committed Q3 earnings decision tree ready for mid-October binary catalyst.
Maintain BNY at current position size with a mandated active overlay—either a 3-month protective put at $140-142 strike with full notional equivalent or a 15-20% tactical trim—to offset documented -0.3% to -1.5% alpha drag from prior passive Holds. The 5.5% capital return yield and structural floor at $135-136 support patience; do not add ahead of Q3 earnings with binary negative technical skew.
Trim BNY exposure by 30-40% into any strength toward $148-152 ahead of Q3 earnings, while maintaining a core long-term position at 60-65% of current weight anchored to the structural floor ($135.66 200 SMA support). Hard stop on remaining position at $135.66; re-engagement requires either a confirmed close above $151.22 on elevated volume with MACD histogram crossing positive, or post-earnings capitulation at $143-145 with bullish RSI divergence. Q3 print mid-October serves as the reassessment gate with upgrade/downgrade criteria tied to fee stabilization and NII performance.
Analysts recommend reducing BNY exposure to 60-65% of current weight through conditional tranches triggered by specific price levels and technical indicators, while retaining a 35-40% residual position anchored to the structural floor at 200 SMA 134-135. The hard stop on the remaining position is set at 144.00, with a full re-evaluation scheduled at Q3 earnings mid-October based on whether results support a beat-and-raise scenario warranting an upgrade to Hold.
Maintain BNY at Hold with explicit active overlay discipline rather than passive benchmark-weight Hold, which produced -0.6% alpha in the prior instance. Execute either a 10-15% position trim or layer a 3-month protective put at $140-142 strike (~5-8% OTM), with trailing stop at $146.66, waiting for the Q3 earnings catalyst mid-October.
Maintain BNY at Hold with active overlay discipline rather than passive benchmark-weight Hold, which has produced negative alpha across recent instances. Implement either a 10–15% position trim or a 3-month protective put (5–8% OTM, ~$140–142 strike) to neutralize negative drift while awaiting the mid-October Q3 earnings catalyst. Add only on confirmed reversal ($153 reclaim with RSI >45) or capitulation pullback ($143–145 on >6M shares with bullish divergence); stop remains at $134.96 weekly close below 200 SMA.
Maintain BNY at Hold with bilateral tripwire architecture rather than initiating fresh capital at $150-$152, which repeats the 0-for-3 aggressive-buy trap documented in recent reflections. The three binding empirical constraints—the aggressive buy trap, the Underweight ceiling, and the Hold base rate alpha—collectively rule out both the aggressive full add and the neutral 0.5% starter tranche, leaving the conservative tripwire-gated Hold as the highest-expected-alpha position.
Maintain BNY Mellon at HOLD rating with benchmark weight while awaiting technical entry confirmation—existing exposure is justified by the structural floor ($134.77 200 SMA providing ~10% cushion) and fortress fundamentals (14% ROE, 29.4% net margins, $62T AUC franchise, $4.5B annual buybacks), but fresh capital should wait for either MACD histogram contraction above $145 or volume-confirmed reclaim of the 10 EMA at $155.36 before initiating new positions.
Maintain BNY at benchmark weight with Hold rating, as the bull case (structural compounder, custody moat, intact 200 SMA, hawkish-Fed tailwind) remains intact while the bear case has not crystallized into a thesis break. Execute with volatility-adjusted sizing so stop at $148.88 represents a tolerable one-day loss given elevated ATR of 3.22, and define bilateral tripwires ($155.48 upside, $148.88 downside, $134 structural exit) that convert passive Hold into a framework responding to evidence rather than ambiguous alpha prints.
Trim BNY exposure by 35-45% to establish an Underweight stance, executing near the $153.89 area with a volatility-adjusted stop at $150.50. Do not initiate new longs; re-entry requires a daily close above the 10 EMA at $156.66 with positive MACD histogram and RSI >40 sustained for three sessions, while structural exit triggers only on weekly close below the 200 SMA at $134. Reassess at Q3 2026 earnings mid-October as the primary decision catalyst.
Maintain BNY at benchmark weight given the premium valuation (P/B 2.61x, 75% above sector peers) and broken medium-term technical structure (price below 10 EMA, 20 SMA, 20 VWAP, and 50 SMA simultaneously), while avoiding fresh initiation into broken momentum. Execute a conditional trim of 10-15% only on confirmed rejection at the $159-$160 zone, with the stop redefined as a daily close below $151.78 rather than intraday break to preserve order-flow memory. Reassess at Q3 2026 earnings in mid-October as the next binary input.
Maintain BNY Mellon at pure benchmark weight with Hold rating as the last three Hold calls produced -0.3% to -1.4% alpha in a regime where bilateral tripwires remain distant. The 2026-09-16 reflection explicitly established that even 0.5% tactical adds violate the 'smallest forced bet' principle, invalidating aggressive Buy, conservative trim, and neutral scaling proposals. Define bilateral tripwires: add only on confirmed RSI>40 reclaim + 50 SMA ($159) close on volume; exit only on weekly close below $134 (200 SMA). Q3 2026 earnings mid-October is the decisive binary catalyst.
Maintain BNY at pure benchmark weight with no tactical adds or trims, as Hold decisions have historically delivered +0.4% to +2.6% alpha while aggressive directional calls at 52-week highs are 0-for-3 and Underweight alpha is capped at -1.5% to -2.5%. Bilateral tripwires (price reclaim above $161.50 or retest of $133.94 200 SMA) and the Q3 2026 earnings catalyst in mid-October will drive the next position change decision.
Maintain BNY at benchmark weight with three tactical tranches adding up to 1.5% of NAV, using a modified stop-loss framework ($149.00 for tactical adds, $151.50 for residual) that addresses the expanding-volatility regime, with hard invalidation at $151.66 close and macro overlays for recession risk and rate repricing.
Trim BNY by 25-35% at the $156-159 range while maintaining residual underweight at 65-75% of benchmark weight, correcting the trader's incoherent $163.24 stop to anchor at the July swing low of $151.68; the technical breakdown is real and multi-indicator (50 SMA lost, MACD bearish cross, RSI collapse 61.85→41.99, lower Bollinger tag at $157.58, above-average volume 3.3M shares) but empirical ceiling lesson from prior 2026-09-11 BNY Underweight (−2.6% alpha despite correct direction) pushes sizing toward measured trim rather than aggressive 50-70% target; bilateral tripwires include re-add on $158.87 reclaim with volume expansion and RSI recovery above 50, second-leg trim on confirmed close below $158.87 toward 50-70% underweight target, and hard invalidation on close above $163.24 with volume greater than 3.5M (upgrade to Hold).
Trim BNY to 70-75% of benchmark weight, scaling sells in tranches into confirmed closes at $165-168 with MACD confirmation. Stop loss set at $170, with Tier 1 re-entry on pullback to $158-160 and Tier 2 re-entry on breakout above $170 on >4M shares. Reassess at Q3 2026 earnings mid-October.
Maintain BNY at current weight without adding at $162.50, as the 5-of-6 Hold base rate with consistent positive alpha decisively favors Hold over directional calls. Execute bilateral tripwire framework with Tier 1 add above $165.70 on >4M shares volume with positive MACD histogram and Tier 2 trim below $157.92 (50 SMA) on >4M shares volume. Actively consider implementing a collar overlay (selling upside strikes near $175 to fund downside protection) to define risk, collect premium income, and hedge AOCI/tail-risk asymmetry.
Maintain BNY at neutral weight without adding at $162.85, as the 5-of-6 Hold base rate favors patience over aggressive directional calls at 52-week highs. The MACD bearish cross, negative histogram, and negative volume divergence signal technical deterioration that makes current entry unfavorable despite solid 5.5% shareholder yield and structural franchise quality. Wait for either a $145-150 pullback with MACD re-confirmation or a breakout above $166.06 on >2.5M shares before scaling exposure.
Maintain neutral weight on BNY at $164.84 given the binding constraint of a 5-of-6 Hold base rate with consistent positive alpha (+0.4% to +2.6%); deploying capital at 52-week highs with MACD bearish cross and unpriced Iran tail risk violates the base rate evidence. Tier 1 add on pullback to $160-162 with RSI reset to low 50s; Tier 2 add on close above $166.06 with >2.5M shares and positive MACD histogram; hard stop at $155.50, downgrade below $148 on >2M shares.
Maintain BNY at neutral weight and do not chase at $164.33, as the current price sits 2.4% above the planned $160.50 entry and below the $165.69 Aug 17 swing-high resistance. Wait for either a Tier 1 pullback to $160-162 with RSI reset to low 50s and recovering MACD histogram, or a Tier 2 breakout above $165.69 on >2.5M shares with positive MACD histogram, before adding exposure.
BNY Mellon carries an Underweight rating based on a failed breakout above $165.69, premium valuation at 16x forward P/E versus a 12-14x historical range, and bearish technical signals including a negative MACD histogram. Reduce existing positions by 10-15% (targeting 60-70% of benchmark weight) rather than liquidating entirely, using $155.50 on above-average volume as a tactical stop. Re-engage only after a confirmed close above $165.69 with volume exceeding 2.5M shares and positive MACD, or on a volume-backed support reversal near $156-157, with full reassessment through Q3 2026 earnings over a 2-4 week tactical window and a 6-12 month structural view.
Maintain Underweight rating while executing a conservative 10-15% staged trim via tranches (10% at $160-162, additional 5% on retest of $164-165 without breaking $165.69) to reduce to 60-70% benchmark weight, avoiding the Research Manager's aggressive 50% cut that replicates the 0-for-3 alpha destruction pattern observed on prior aggressive Underweights at 52-week highs.
Reduce BNY to ~75-80% of benchmark weight via a calibrated 15-20% tranche-based trim (10% at $160-162, additional 5-10% on retest of $164-165) executed in the $160-165 zone, with stop at $165.70 on retained position; the rating stays Underweight rather than Sell because the franchise quality and 5.7% capital return yield (1.39% dividend + ~4.3% buyback) provide a structural floor warranting meaningful core retention.
Maintain neutral weight on BNY as three analysts converged on Hold; Underweights near 52-week highs have gone 0-for-3 on alpha capture while Holds delivered consistent positive alpha. Scale in 25-33% of intended position size only on a confirmed daily close at or below $155.50 with RSI >45 or stabilizing MACD histogram, with a hard stop at $154.50 closing basis.
Maintain neutral weight on BNY with a $155 price target; the base rate decisively favors Hold (5 of 6 positive alpha vs 0-for-3 on Underweights at 52-week highs), with all three analysts converging on Hold despite tactical disagreement. Hard invalidation triggers on daily close below $155.01 50 SMA on above-average volume; re-entry requires confluence of price breakout above $165.69 with >2.5M volume and positive MACD histogram.
Maintain BNY at neutral weight with a hard stop at $154.50 (50 SMA / lower Bollinger Band confluence); trim 5-8% tactically into any pre-Jackson Hole strength above $163 to reduce binary-event exposure. Re-entry triggers are a confirmed close above $165.89 on >2.5M shares for bullish continuation, or a pullback to the $145-150 zone with basing confirmation for a better entry. The base-rate evidence favoring Holds over both Buy and Underweight is stronger than any individual signal in the current debate.
Maintain an Underweight rating on BNY with a trim of 25-35% relative to benchmark weight on any rally into the $165-166 zone while retaining 65-75% of the position, justified by a three-dimensional bearish convergence including MACD divergence, deposit-beta widening, and peer-high valuation without premium returns. Use $161.43 (10 EMA) as a tactical trailing stop warning and $154.50 (50 SMA close on volume) as the structural floor and hard thesis-invalidation level.
Analysts recommend trimming 25-30% of BNY Mellon on rallies to the $165-166 resistance zone (third test of upper Bollinger band), retaining 70-75% of the position with stops below $157, while pre-committing to tiered re-entry at $160-162, $153-156, and above $165.50. The Underweight rating is supported by converging bearish technical signals, stretched valuation (P/E 19x, P/B 2.78x), and $62B AFS portfolio duration risk, though structural franchise quality (40% operating margin, 14% ROE, 5.7% shareholder yield) prevents a full Sell rating.
Maintain BNY at neutral weight; do not add at current $162 levels. The topping pattern (lower highs at 164.27→163.93, failed 165.08 retest, MACD bearish cross) and 87% no-cut consensus priced in argue against aggressive Overweight, while the conservative stop proposal at $157 violates ATR discipline. Tactical adds are appropriate only at the $158-160 confluence zone with RSI >50, using an ATR-calibrated stop at $153.50.
Maintain BNY Mellon at neutral weight and do not add at $158.49, as the forward P/E of 15.5x on $10.25 consensus EPS implies a fair value of ~$159 with no multiple expansion catalyst available. Anchor the tactical stop at $148 (3.4 ATR below current), with $152.77 as the structural backstop layer, and establish tiered re-entry zones at $145–$148, $152–$155, and above $165.69. Re-evaluate at Q3'26 earnings in mid-October, upgrading to Overweight on beat-and-raise with fee-driven growth or downgrading to Underweight on a close below $148 with elevated volume or NII guidance cut.
Maintain BNY at neutral weight and avoid adding at $157.24 as the technical breakdown remains unresolved. Wait for a 25-40% scaled starter entry at the $152-156 confluence zone on a constructive reversal candle, with hard stop at $148.90 and tactical trailing stop at $155. Trim 20-30% on confirmed close below $152 with volume, plus an additional 10-15% pre-emptive trim if price closes below the 50 SMA for three consecutive sessions. Re-evaluate at Q3 2026 earnings in mid-October.
Analysts unanimously recommend HOLD on BNY at $159.76, citing convergence of technical deteriorations (MACD bearish cross, RSI collapse, distribution on 2.33M volume) and macro headwinds (28% September hike probability, oil at $92) against structural franchise quality (14.1% ROE, $50T+ AUC, 4.6% total shareholder yield). The recommended deployment strategy is to wait for the $152.70–$153.50 primary buy zone, using only half the standard first-tranche size with tightened confirmation filters, while maintaining a $155 tactical trailing stop and $152.72 structural backstop, reserving subsequent tranches ($148–$150, $145) for lower levels.
Trim 15-20% of BNY at $163.50 to lock in gains given full valuation (19x P/E, 2.79x P/B) and a 39% YTD advance, while retaining 80-85% core exposure with a $159 closing stop; redeploy trimmed capital into complementary bank names (USB, BAC, or BKMC) rather than waiting for a multi-condition re-entry trigger, deferring fresh BNY capital until post-Q3 earnings (mid-October) assessment of whether the SG&A spike and AFS book expansion prove transitory.
Trim 20-25% of BNY at $164 to lock in gains from the 297% three-year run while preserving 75-80% participation in the intact structural trajectory, using a thesis-invalidation framework (close below $150.60 on >2M volume, MACD turning negative, confirmed Fed hike, or adverse Canadian litigation ruling) rather than a fixed $175 hard stop that risks getting harvested by routine 1.5-2 ATR extensions in a confirmed uptrend.
Trim BNY 20-25% at current levels to reduce concentration and lock in gains from the 297% three-year run, while retaining 75-80% of exposure with a $150 closing stop positioned below the 50 SMA at $151.49. Re-entry is tied to Q3 2026 earnings (October) rather than price triggers — a beat-and-raise with volume-driven NII growth would warrant moving back to Hold, while a miss or NII guidance cut would warrant Sell.
Maintain BNY Mellon at Hold rating with Overweight tilt; the aggressive analyst's 1:1 risk-reward math is incorrect (actual R/R is 0.69:1), and the $162.25 entry violates the Research Manager's protocol, but three defined triggers (tactical add at $159.50-$160.50, breakout add at $163.66 with 2.5M+ shares, aggressive add at $151-$152 on 50 SMA test) provide active participation without chasing; hard stop at $149.50 with $150.60 trailing stop if price stalls below $158.
Maintain BNY position unchanged as the stock sits 28% above its 200 SMA with unresolved MACD divergence and a buyback-adjusted PEG of 1.3-1.7x, making new capital deployment unattractive at $162.93 despite a structurally strong fundamental trajectory of five consecutive growth quarters and record $5.34B revenue. Use a 50 SMA/ATR-based trailing stop near $150.60 on the existing position while pre-committing to add triggers at $148-152 pullback with RSI reset or $163.26+ breakout with >2.5M shares volume confirmation.
Maintain BNY position unchanged at Hold. The prior Underweight calls on this ticker both lost alpha by 0.9-1.2%, validating that Neutral with a hard structural stop is the better default when bearish technical signals lack concrete catalysts. Pre-defined add triggers exist on both sides: a pullback to $148-152 or a volume-confirmed breakout above $163.12 on >$3M shares with two-session confirmation, targeting $170 and $175-180.
Trim BNY to 50–65% of benchmark weight (near the lower end) at current levels around $159, using a closing stop at $148 on the retained core to avoid intraday shakeouts; stage re-entry at half-size on a confirmed hold above $149.75 with MACD re-engaging, then commit the second half on a volume-confirmed break above $163.12.
Analysts recommend trimming 25-30% of BNY near $157 to lock in gains at 52-week highs, retaining a 70-75% core position. The trader's proposed stop at $162.34 should be replaced with a genuine protective stop at $151.90 (the structural break level both sides agree on), as it functions as a profit-take rather than risk protection. Re-engagement is recommended either on a pullback to $151.90-$152.50 for improved risk/reward, or on a volume-confirmed breakout above $162.34 with positive MACD histogram confirmation.
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.